Expert Review of Molecular Diagnostics
Journal Title
- Expert Review of Molecular Diagnostics
ISSN
- E 1744-8352 | P 1473-7159 | 1473-7159 | 1744-8352
Publisher
- Future Drugs Ltd.
Listed on(Coverage)
| JCR | 2005-2019 |
|---|---|
| SJR | 2002-2019 |
| CiteScore | 2011-2019 |
| SCIE | 2010-2021 |
| CC | 2016-2021 |
| SCOPUS | 2017-2020 |
| MEDLINE | 2016-2021 |
| EMBASE | 2016-2020 |
Active
- Active
based on the information
- SCOPUS:2020-10
Country
- NORWAY
Aime & Scopes
- Expert Review of Molecular Diagnostics (ISSN 1473-7159) publishes expert reviews of the latest advancements in the field of molecular diagnostics including the detection and monitoring of the molecular causes of disease that are being translated into groundbreaking diagnostic and prognostic technologies to be used in the clinical diagnostic setting. Each issue of Expert Review of Molecular Diagnostics contains leading reviews on current and emerging topics relating to molecular diagnostics, subject to a rigorous peer review process; editorials discussing contentious issues in the field; diagnostic profiles featuring independent, expert evaluations of diagnostic tests; meeting reports of recent molecular diagnostics conferences and key paper evaluations featuring assessments of significant, recently published articles from specialists in molecular diagnostic therapy. Expert Review of Molecular Diagnostics provides the forum for reporting the critical advances being made in this ever-expanding field, as well as the major challenges ahead in their clinical implementation. The journal delivers this information in concise, at-a-glance article formats: invaluable to a time-constrained community. Key areas of coverage include: /// Contemporary genetic and genomic technologies including deep sequencing and genome-wide association studies /// Molecular tools for infectious disease testing and detection of multiply-resistant bacteria /// Latest discoveries in oncology diagnostics /// Progress in non-invasive prenatal testing, including molecular markers and ethical considerations /// 'Omic’ diagnostic technologies including: pharmacogenomic, epigenomic, proteomic and metabolomic technologies /// Disease predisposition and inherited genetic diseases testing /// Diagnostic tests for point-of-care settings and for resource-limited settings /// Progress in developing handheld devices for molecular diagnostic tests /// Biomarker development and usage to target patient groups for personalized medicine /// Tools for molecular prognosis /// Novel technologies and developments in molecular diagnostic techniques /// Regulatory, ethical and payor perspectives in molecular diagnostics